With revenue up 9%, why does the NIB share price keep falling?

Will the ailing share price make a full recovery?

| More on:
Stethoscope with a piggy bank in the middle.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The NIB Holdings Limited (ASX: NHF) share price has suffered a very unhealthy decline of 27% in the past 12 months. That's despite the S&P/ASX 200 Index (ASX: XJO) rising roughly 12%, meaning the ASX healthcare share has underperformed by close to a whopping 40%.

Created with Highcharts 11.4.3NIB Holdings PriceZoom1M3M6MYTD1Y5Y10YALL12 Feb 202412 Feb 2025Zoom ▾Mar '24May '24Jul '24Sep '24Nov '24Jan '25Apr '24Apr '24Jul '24Jul '24Oct '24Oct '24Jan '25Jan '25www.fool.com.au

The decline has also happened despite NIB still growing in scale during this period, so it begs the question of what's going on and whether this is an opportunity. It grew its revenue by 9% in FY24.

It's normal for there to be difficulties for specific industries sometimes. Private health insurance is a niche industry compared to general insurance, in my view, with more complexity due to private hospitals and government funding involvement.

What's going on in the private health industry?

Operators like NIB and Medibank Private Ltd (ASX: MPL) are partly dependent on the overall health of the private system.

Investment bank Goldman Sachs thinks industry policyholder growth has remained "resilient" through the first half of FY25 ("perhaps surprising to the upside", in the broker's words), though it notes weakening affordability for Australians. This may be a key driver of the NIB share price, in my view.

Goldman Sachs also suggested that the "competitive environment for policyholder acquisition is still strong resulting in lapses / churn reverting toward pre-COVID levels".

Policyholder growth has been supported by factors like population growth, first-time take-ups of private health insurance, and younger age groups, according to Goldman Sachs.

The industry has been under pressure to keep a lid on premium increases to help affordability and reduce inflation. However, Goldman Sachs believes the April 2025 approved premium rate increases could be higher than 2024 because of "hospital indexation/inflation (including nurse wages) as well as higher bed rates for private patients in NSW public hospitals."

The broker is concerned that the risks for the profit margins of NIB (and Medibank) "are building with inflationary pressures and low approved premium rate increases". NIB is expecting to achieve net margins within its target net margin range of between 6% and 7%.

Is the NIB share price attractive?

The group underlying operating profit (UOP) guidance from NIB is $235 million to $250 million, with Goldman Sachs thinking NIB will be at the bottom end of that range.

Overall, for the FY25 first-half result, the broker expects NIB to achieve insurance revenue of $1.71 billion, an insurance operating profit of $93.6 million, and an underlying operating profit of $101.4 million. The forecast FY25 half-year dividend is 11.1 cents per share.

For the full FY25 result, Goldman Sachs projects $3.7 billion of revenue, $216.7 million of insurance operating profit, and $236.5 million of underlying operating profit, with a possible annual dividend per share of 26.5 cents.

At the current NIB share price, it's valued at 15x FY25's estimated earnings with a possible grossed-up dividend yield, including franking credits.

If investors are interested in NIB shares, then I'd say this is the right time to look at the company. Goldman Sachs currently has a buy rating on NIB shares with a price target of $6.50, implying a possible 12-month rise of just over 10% from where it is today.

Should you invest $1,000 in Bitcoin.ℏ right now?

Before you buy Bitcoin.ℏ shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Bitcoin.ℏ wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 30 April 2025

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Goldman Sachs Group. The Motley Fool Australia has positions in and has recommended NIB Holdings. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A man has a surprised and relieved expression on his face. as he raises his hands up to his face in response to the high fluctuations in the Galileo share price today
Healthcare Shares

Guess which ASX All Ords stock is rocketing 58% on big US news

What is getting investors excited today? Let's find out.

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

3 reasons to buy this quality ASX 200 healthcare share today

A leading expert expects this outperforming ASX 200 healthcare share will keep running hot.

Read more »

A woman reclines in a comfortable chair while she donates blood holding a pumping toy in one hand and giving the thumbs up in the other as she is attached to a medical machine to collect her blood donation.
Healthcare Shares

Brokers tip 4 ASX 200 healthcare shares to buy now

Healthcare is a defensive sector that can provide useful cover for investors when the market is volatile.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

How Trump's tariffs have created 'upside potential' for CSL shares

A leading expert says CSL shares are now looking ‘cheap’.

Read more »

Shot of a young scientist looking stressed out while working on a computer in a lab.
Healthcare Shares

Telix shares crash 8% on US FDA blow

This high-flying stock has been hit with some bad news.

Read more »

A man wakes up happy with a smile on his face and arms outstretched.
Healthcare Shares

ResMed shares jump 8% on strong Q3 update

It was yet another strong quarter from this high-quality company.

Read more »

A woman jumps for joy with a rocket drawn on the wall behind her.
Healthcare Shares

Guess which ASX All Ords stock is up 10% on big news

This high-flying stock just can't stop rising. What's going on?

Read more »

Teamwork, planning and meeting with doctors and laptop for medical, review and healthcare. Medicine, technology and internet with group of people for collaboration, diversity and support in hospital
Healthcare Shares

Telix shares rocket 15% on stellar Q1 sales update

Let's see how the company performed during the three months.

Read more »